Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Karo Bio synthesizes new estrogen receptor-beta ligands

May 4, 2011

Jenrin Discovery presents new cannabinoid CB1 receptor antagonists/inverse agonists

May 4, 2011

New GPR119 receptor modulators designed at IRM

May 4, 2011

Phase II data presented on Androxal in men with hypogonadism and type 2 diabetes

May 3, 2011

LCT receives approval to conduct phase II trial of Diabecell in Argentina

May 3, 2011

Recordati launches pitavastatin in Spain for dyslipidemia

May 3, 2011

Boehringer Ingelheim and Lilly receive FDA approval for Tradjenta tablets in type 2 diabetes

May 3, 2011

Efficacy of linagliptin in type 2 diabetes is independent of body mass index

May 3, 2011

FDA approves Abbott's AndroGel 1.62% for treatment of men with hypogonadism

May 2, 2011

HemaQuest Pharma enrolls first patient in phase II HQK-1001 trial

May 2, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...